In vitro susceptibility of 4903 bacterial isolates to gemifloxacin—an advanced fluoroquinolone

Decreased Susceptibility of<i>Streptococcus pneumoniae</i>to Fluoroquinolones in Canada

Danny K. Chen, Allison McGeer, Joyce C. de Azavedo et al. · New England Journal of Medicine · 1999 · 994 citations · Full text

Worldwide Prevalence of Antimicrobial Resistance in<i>Streptococcus pneumoniae, Haemophilus influenzae,</i>and<i>Moraxella catarrhalis</i>in the SENTRY Antimicrobial Surveillance Program, 1997–1999

D. J. Hoban, G V Doern, A. C. Fluit et al. · Clinical Infectious Diseases · 2001 · 375 citations

Antimicrobial Chemotherapy, Antibiotic Resistance, Bacterial Pathogens +22

Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of <i>Streptococcus pneumoniae</i>

Joseph M. Blondeau, Xilin Zhao, Glen Hansen et al. · Antimicrobial Agents and Chemotherapy · 2001 · 313 citations · Full text

Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms

Joseph M. Blondeau, Roman A. Laskowski, Jaime Bjarnason et al. · International Journal of Antimicrobial Agents · 2000 · 95 citations

Gram-positive Organisms, Antimicrobial Susceptibility, Antibiotics +9

Antimicrobial Resistance among Clinical Isolates of <i>Streptococcus pneumoniae</i> in Canada during 2000

Donald E. Low, Joyce de Azavedo, Karl Heinz Weiss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 93 citations · Full text